Digital Discovery Strategies Accelerate Novel Antibiotic Innovation Against AMR

The global health crisis of Antimicrobial Resistance (AMR) is escalating, with antibiotic development failing to keep pace with evolving bacterial resistance. Traditional antibiotic discovery, often reliant on "dirt mining" and phenotypic screening, has become slow and inefficient, leading to a critical shortage of novel agents. There is an urgent need for discovery strategies that are faster, broader, and more systematic to identify new chemical structures and biological sequences capable of combating resistant pathogens. This gap necessitates innovative approaches that leverage modern computational and biological tools.